PR
Praxis Precision Medicines
PRAX13F as of Jun 30, 2026 · next update ~Nov 14
Limited coverage
Only 1 fund we track owns this stock, so quarterly sentiment and aggregates may be sparse.
Who's buying PRAX
Top funds mostly trimmed Praxis Precision Medicines in Q2 (Apr–Jun)
Buying:
FundsInsidersCongress1
- Top funds0 of 1 bought more, 1 sold some. Largest: Polen Capital Management, $2.4M (0% of its portfolio).
- InsidersNo buys, 3 sales in 12 months.
- Congress1 member bought (2 trades), 0 sales in 12 months.
1 fund$2.4M held0.0% avg. weightQ2: 0 bought / 1 sold
13F reports are a snapshot as of Jun 30, 2026; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).
Share price · market data, not from 13F reports
Q2 2026